Cargando…
Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform
Emerging and re-emerging zoonotic viral diseases are major threats to global health, economic stability, and national security. Vaccines are key for reducing coronaviral disease burden; however, the utility of live-attenuated vaccines is limited by risks of reversion or repair. Because of their hist...
Autores principales: | Graham, Rachel L., Deming, Damon J., Deming, Meagan E., Yount, Boyd L., Baric, Ralph S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206136/ https://www.ncbi.nlm.nih.gov/pubmed/30393776 http://dx.doi.org/10.1038/s42003-018-0175-7 |
Ejemplares similares
-
Sars Coronavirus Vaccine Development
por: Baric, Ralph S., et al.
Publicado: (2006) -
Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
por: Agnihothram, Sudhakar, et al.
Publicado: (2014) -
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
por: Enjuanes, Luis, et al.
Publicado: (2008) -
Sars Coronavirus Accessory ORFs Encode Luxury Functions
por: Frieman, Matthew B., et al.
Publicado: (2006) -
Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform
por: Agnihothram, Sudhakar, et al.
Publicado: (2018)